Live Cell Imaging Market Is Predicted To Grow Quickly Due To Rising Popularity Of Kinetic Research Over Fixed Cellular Analysis Till 2025: Grand View Research, Inc.
The global live cell imaging market is
expected to reach USD 9.3 billion by 2025, according to a new report by Grand
View Research, Inc. Rising popularity of kinetic research over fixed cellular
analysis is the key driver. Addition of dyes and reagents alter the cell
behavior, mostly in a negative manner, which does not showcase the natural
course of action of the cellular functions. Understanding the cellular behavior
in its natural state is crucial in drug discovery and targeted drug therapy.
This, in turn, increases the need for live cell imaging, thus boosting the
market.
In a survey by Drug Discovery
World Spring, almost 21% researchers prefer & use live cell imaging and 31%
plan to use it in the future. Moreover, 38% of the respondents were interested
in using live cell kinetic HCS imaging in the future. The most important
feature for researchers is the ability to automate the incubation and image
capturing of any live cell analyzer. Secondly, they also give importance to
viable cell-tracking ability of the equipment. Further development in the
technology of equipment is expected to fulfill these criteria and boost the
utility of the same over the forecast period.
Development in delivering probes
in living cells, targeting organelles, and proteins using some of the
techniques has increased use and adoption of live cell imaging in research and
other applications. With improved fluorescent probes, the techniques such as
Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.
Browse full research report on Live Cell Imaging Market: http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market
Further Key Findings From The Report Suggest:
- Equipment dominated the product segment in 2016. The
current system, although of great potential are still expected to perform
better over the next few years. The general trend is to make the
instruments compact and integrated for end-to-end processing.
- Cell biology dominated the application with more than
30% of the shares and was closely followed by developmental biology. Stem
cell and drug discovery are the upcoming fields to apply live cell imaging
in the research.
- North America dominated due to its high investment
rate and technologically sound infrastructure. The research firms present
in this region are technologically aware, hence, readily invest in high
cost equipment.
- Asia Pacific is expected to show fastest growth over
the forecast period due to increasing application of these imaging
techniques in drug discovery and personalized medicine.
- Key players includes Carl Zeiss Meditec AG; Leica
Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE
Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.;
Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global live cell
imaging market on the basis of product, application, technology, and region:
Live Cell Imaging Product Outlook (Revenue, USD
Million, 2014 - 2025)
- Equipment
- Consumable
- Software
Live Cell Imaging Application Outlook (Revenue, USD
Million, 2014 - 2025)
- Cell
Biology
- Developmental
Biology
- Stem
Cell & Drug Discovery
- Others
Live Cell Imaging Technology Outlook (Revenue, USD
Million, 2014 - 2025)
- Time
lapse Microscopy
- Fluorescence
recovery after photobleaching (FRAP)
- Fluorescence
resonance energy transfer (FRET)
- High
content screening (HCS)
- Others
Live Cell Imaging Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-live-cell-imaging-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment